Semin Liver Dis 2000; Volume 20(Number 01): 0001-0016
DOI: 10.1055/s-2000-9506
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4663

Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends

Annemarie Wasley, Miriam J. Alter
  • Hepatitis Branch, Centers for Disease Control and Prevention, Atlanta, Georgia
Further Information

Publication History

Publication Date:
31 December 2000 (online)

ABSTRACT

Hepatitis C Virus (HCV) infection appears to be endemic in most parts of the world, with an estimated overall prevalence of 3%. However, there is considerable geographic and temporal variation in the incidence and prevalence of HCV infection. Using age-specific prevalence data, at least three distinct transmission patterns can be identified. In countries with the first pattern (e.g., United States, Australia), most infections are found among persons 30-49 years old, indicating that the risk for HCV infection was greatest in the relatively recent past (10-30 years ago) and primarily affected young adults. In countries with the second pattern (e.g., Japan, Italy), most infections are found among older persons, consistent with the risk for HCV infection having been greatest in the distant past. In countries with the third pattern (e.g., Egypt), high rates of infection are observed in all age groups, indicating an ongoing high risk for acquiring HCV infection. In countries with the first pattern, injection drug use has been the predominant risk factor for HCV infection, whereas in those with the second or third patterns, unsafe injections and contaminated equipment used in healthcare-related procedures appear to have played a predominant role in transmission. Much of the variability between regions can be explained by the frequency and extent to which different risk factors have contributed to the transmission of HCV. Because different strategies are required to interrupt different patterns of HCV transmission, determining the epidemiology of HCV infection in areas where that information has not yet been assessed is critical for developing appropriate prevention programs.

REFERENCES

  • 1 WHO. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.  J Viral Hepat . 1999;  6 35-47
  • 2 Dow B C, Coote I, Munru H. Confirmation of hepatitis C virus antibody in blood donors.  J Med Virol . 1993;  41 215-220
  • 3 Mutimer D J, Harrison R F, O'Donnell K B. Hepatitis C virus infection in the asymptomatic British blood donor.  J Viral Hepat . 1995;  2 47-53
  • 4 Atrah H I, Ala F A, Ahmed M M. Unexplained hepatitis C virus antibody seroconversion in established blood donors.  Transfusion . 1996;  36 339-343
  • 5 Mathiesen U L, Karlsson E, Foberg U. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced posttransfusion hepatitis C after open-heart surgery.  Scand J Gastroenterol . 1993;  28 581-584
  • 6 Nordoy I, Schrumpf E, Elgjo K. Liver disease in anti-hepatitis C virus-positive Norwegian blood donors.  Scand J Gastroenterol . 1994;  29 77-81
  • 7 Hennig H, Haase D, Kirchner H. Prevalence of hepatitis C virus in blood donors and comparison of 4 different anti-HCV differentiation tests.  Beitr Infsuionsther Transfuisonsmed . 1996;  33 231-234
  • 8 Riggert J, Schwartz D W, Uy A. Risk of hepatitis C virus (HCV) transmission by anti-HCV-negative blood components in Austria and Germany.  Ann Hematol . 1996;  72 35-39
  • 9 Caspari G, Gerlich W H, Beyer J, Schmitt H. Non-specific and specific anti-HCV results correlated to age, sex, transaminase, rhesus blood group and follow-up in blood donors.  Arch Virol . 1997;  142 473-489
  • 10 Ranger S, Martin P, Roussane M C, Denis F. Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Limoges, France.  Gut . 1993;  34(2 Suppl) S50-S51
  • 11 Kleinman S, Alter H, Busch M. Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay.  Transfusion . 1992;  32 805-813
  • 12 Murphy E L, Bryzman S, Williams A E. Demographic determinants of hepatitis C seroprevalence among blood donors.  JAMA . 1996;  275 996-1000
  • 13 Zhang Y Y, Guo L S, Hao L J. Antibodies to hepatitis C virus and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction.  Chin Med J . 1993;  106 171-174
  • 14 Garcia Z, Taylor L, Ruano A. Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development.  J Med Virol . 1996;  49 218-222
  • 15 Pita-Ramirez L, Torres-Ortiz G E. Prevalence of viral antibodies and syphilis serology in blood donors from a hospital.  Rev Invest Clin . 1997;  49 475-480
  • 16 Ayala Gaytan J J, Guerra Avalos J F, Brondo Mora P, Casillas Roma A. Prevalence of viral markers for hepatitis B, C and human immunodeficiency virus in volunteer blood donors in Northeast Mexico.  Rev Gastroenterol Mexico . 1997;  62 250-253
  • 17 Guerrero-Romero J F, Castaneda A, Rodriguez-Moran M. Prevalence of risk factors associated with hepatitis C in blood donors in the municipality of Durango, Mexico.  Salud Publica Mex . 1996;  38 94-100
  • 18 Munoz G, Velasco M, Thiers V. Prevalence and genotypes of hepatitis C virus in blood donors and in patients with chronic liver disease and hepatocarcinoma in a Chilean population.  Rev Med Chile . 1998;  126 1035-1042
  • 19 Mison L M, Young I F, O'Donoghue M. Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population.  Transfusion . 1997;  37 73-78
  • 20 Triki H, Said N, Ben Salah A. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia.  Trans R Soc Trop Med Hyg . 1997;  91 11-14
  • 21 Abid S, Fkih S, Khlass B. Screening and confirmation of anti-HCV antibodies in Tunisian blood donors.  Transfus Clin Biol . 1997;  4 221-226
  • 22 Soni P N, Tait D R, Kenoyer D G. Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus.  J Med Virol . 1993;  40 65-68
  • 23 Vasconcelos H C, Yoshida C F, Vanderborght B O, Schatzmayr H G. Hepatitis B and C prevalences among blood donors in the south region of Brazil.  Mem Inst Oswaldo Cruz . 1994;  89 503-507
  • 24 Edelenyi-Pinto M, Carvalho A P, Nogueira C. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.  Mem Inst Oswaldo Cruz . 1993;  88 305-307
  • 25 Hadziyannis S J, Giannoulis G, Hadziyannis E. Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma.  J Hepatol . 1993;  17(Suppl 3) S72-S77
  • 26 Mihaljevic I, Feldbauer J, Delajlija M, Grgicevic D. Antibodies to hepatitis C virus in Croatian blood donors and polytransfused patients.  Vox Sang . 1992;  63 236
  • 27 Gloskowska-Moraczewska Z, Kacperska E, Seyfried H. Evaluation of screening and complementary tests for anti-HCV antibodies.  Acta Haematol Pol . 1993;  24 273-280
  • 28 Lai M E, Mazzoleni A P, Farci P. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.  J Med Virol . 1993;  41 282-288
  • 29 Abdourakhamanov D T, Hasaev A S, Castro F J, Guardia J. Epidemiological and clinical aspects of hepatitis C virus infection in the Russian Republic of Daghestan.  Eur J Epidemiol . 1998;  14 549-553
  • 30 Barna T K, Ozsvar Z, Szendrenyi V, Gal G. Hepatitis C virus antibody in the serum of blood donors.  Orvosi Hetilap . 1996;  137 507-511
  • 31 Al-Faleh F Z, Ramia S, Arif M. Profile of hepatitis C virus and the possible modes of transmission of the virus in the Gizan area of Saudi Arabia: a community-based study.  Ann Trop Med Parasitol . 1995;  89 431-437
  • 32 El Guneid A M, Gunaid A A, O'Neill A M. Prevalence of hepatitis B, C and D virus markers in Yemeni patients with chronic liver disease.  J Med Virol . 1993;  40 330-333
  • 33 Panigrahi A K, Panda S K, Dixit R K. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver diseases.  J Med Virol . 1997;  51 167-174
  • 34 Jaiswal S P, Chitnis D S, Naik G. Prevalence of anti-HCV antibodies in central India.  Indian J Med Res . 1996;  104 177-181
  • 35 Irshad M, Acharya S K, Josha Y K. Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Delhi.  Indian J Med Res . 1995;  102 162-164
  • 36 Frommel D, Tekle-Haimanot R, Berhe N. A survey of antibodies to hepatitis C virus in Ethiopia.  Am J Trop Med Hyg . 1993;  49 435-439
  • 37 Wansbrough-Jones M H, Frimpong E, Cant B. Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana.  Trans R Soc Trop Med Hyg . 1998;  92 496-499
  • 38 Lo B B, Meymouna M, Boulahi M A. Prevalence of serum markers of hepatitis B and C virus in blood donors of Nouakchott, Mauritania.  Bull Soc Pathol Exot . 1999;  92 83-84
  • 39 Develoux M, Boni G, Aguessy Ahyi B. The prevalence of anti-hepatitis C antibodies in pregnant women and blood donors in Benin.  Bull Soc Pathol Exot . 1995;  88 115-116
  • 40 Jeannel D, Fretz C, Traore Y. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotrypes 1 and 2 in West Africa.  J Med Virol . 1998;  55 92-97
  • 41 Ilako F M, McLigeyo S O, Riyat M S. The prevalence of hepatitis C virus antibodies in renal patients, blood donors and patients with chronic liver disease in Kenya.  East Afr Med J . 1995;  72 362-364
  • 42 Hayashi J, Furusyo N, Sawayama Y. Hepatitis G virus in the general population and in patients on hemodialysis.  Dig Dis Sci . 1998;  43 2143-2148
  • 43 Nakashima K, Kashiwagi S, Hayashi J. Prevalence of hepatitis C virus infection among female prostitutes in Fukuoka, Japan.  J Gastroenterol . 1996;  31 664-668
  • 44 Sakugawa H, Nakasone H, Nakayoshi T. High proportion of false positive reactions among donors with anti-HCV antibodies in a low prevalence area.  J Med Virol . 1995;  46 334-338
  • 45 Yamaguchi K, Kiyokawa H, Machida J. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.  FEMS Microbiol Rev . 1994;  14 253-258
  • 46 Wang Y, Tao Q M, Zhao H Y. Hepatitis C virus RNA and antibodies among blood donors in Beijing.  J Hepatol . 1994;  21 634-640
  • 47 Wu X. Investigation on anti-HCV antibody in Shashi District.  Chin J Epidemiol . 1993;  14 331-333
  • 48 Tang S. Seroepidemiological study on hepatitis C virus infection among blood donors from various regions in China.  Chin J Epidemiol . 1993;  14 271-274
  • 49 Zhang Y Y, Hansson B G, Widell A, Nordenfelt E. Hepatitis C virus antibodies and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction.  APMIS . 1992;  100 851-855
  • 50 Duraisamy G, Zuridah H, Ariffin M Y. Prevalence of hepatitis C virus antibodies in blood donors in Malaysia.  Med J Mal . 1993;  48 313-316
  • 51 Kuperan P, Choon A T, Ding S H, Lee G. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population in Singapore.  Southeast Asian J Trop Med Pub Health . 1993;  24(Suppl 1) 127-129
  • 52 Apichartpiyakul C, Apichartpiyakul N, Urwijitaroon Y. Seroprevalence and subtype distribution of hepatitis C virus among blood donors and intravenous drug users in northern/northeastern Thailand.  Jpn J Infect Dis . 1999;  52 121-123
  • 53 Songsivilai S, Jinathongthai S, Wongsena W. High prevalence of hepatitis C infection among blood donors in northeaster Thailand.  Am J Trop Med Hyg . 1997;  57 66-69
  • 54 Sawanpanyalert P, Boonmar S, Maeda T. Risk factors for hepatitis C virus infection among blood donors in an HIV-epidemic area in Thailand.  J Epidemiol Commun Health . 1996;  50 174-177
  • 55 Darmadi S, Soetjipto, Handajani R. Hepatitis C virus infection-associated markers in sera from blood donors in Surabaya, Indonesia.  Microbiol Immunol . 1996;  40 401-405
  • 56 Soetjipto, Handajani R, Lusida M I. Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis and patients with hepatocellular carcinoma in Surabaya, Indonesia.  J Clin Microbiol . 1996;  34 2875-2880
  • 57 Saleh M G, Pereira L M, Tibbs C J. High prevalence of hepatitis C virus in the normal Libyan population.  Trans R Soc Trop Med Hyg . 1994;  88 292-294
  • 58 Bassily S, Hyams K C, Fouad R A. A high risk of hepatitis C infection among Egyptian blood donors: the role of parenteral drug abuse.  Am J Trop Med Hyg . 1995;  52 503-505
  • 59 Darwish M A, Raouf T A, Rushdy P. Risk factor associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors.  Am J Trop Med Hyg . 1993;  49 440-447
  • 60 Attia M A, Zekri A R, Goudsmit J. Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors.  J Clin Microbiol . 1996;  34 2665-2669
  • 61 Alter M J, Kruszon-Moran D, Nainan O V. Prevalence of hepatitis C virus infection in the United States, 1988-1994.  N Engl J Med . 1999;  341 556-562
  • 62 Lowe D, Cotton R. Hepatitis C: a review of Australia's response. Publications Production Unit, Commonwealth Department of Health and Aged Care, Commonwealth of Australia, Canberra, 1999
  • 63 Farrell G C, Weltman M, Dingley J, Lin R. Epidemiology of hepatitis C virus infection in Australia.  Gastroenterol Jpn . 1993;  28(Suppl 5) 32-36
  • 64 Armstrong G L, Alter M J, McQuillan G M. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.  Hepatology . 2000;  31 777-782
  • 65 Alter M J. Epidemiology of hepatitis C.  Hepatology . 1997;  26 62S-65S
  • 66 Tanaka E, Kiyosawa K, Sodeyama T. Prevalence of antibody to hepatitis C virus in Japanese school children: comparison with adult blood donors.  Am J Trop Med Hyg . 1992;  46 460-464
  • 67 Ishibasi M, Shinzawa H, Kuboki M, Tsuchida H, Takahashi T. Prevalence of inhabitants with anti-hepatitis C virus antibody in an area following an acute hepatitis C epidemic: age and area-related features.  J Epidemiol . 1996;  6 1-7
  • 68 Guadagnino V, Stroffolini T, Rapicetta M. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in Southern Italy.  Hepatology . 1997;  26 1006-1011
  • 69 Stroffolini T, Menchinelli M, Taliani G. High prevalence of hepatitis C virus infection in a small central Italian town: lack of evidence of parenteral exposure.  Ital J Gastroenterol . 1995;  27 235-238
  • 70 Abdel-Wahah M F, Zakaria S, Kamel M. High seroprevalence of hepatitis C infection among risk groups in Egypt.  Am J Trop Med Hyg . 1994;  51 563-567
  • 71 Mohamed M K, Hussein M H, Massoud A A. Study of the risk factors for viral hepatitis C infection among Egyptians applying for work abroad.  J Egypt Public Health Assoc . 1996;  71 113-142
  • 72 Villano S A, Vlahov D, Nelson K E, Lyles C M, Cohn S, Thomas D L. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.  J Clin Microbiol . 1997;  35 3274-3277
  • 73 Garfein R S, Doherty M C, Monterroso E R, Thomas D L, Nelson K E, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.  J Acquir Immune Defic Syndr Hum Retrovirol . 1998;  18(Suppl 1) S11-S19
  • 74 Crofts N, Hopper J L, Bowden D S, Breschkin A M, Milner R, Locarnini S A. Hepatitis C virus infection among a cohort of Victorian injecting drug users.  Med J Aust . 1993;  159 237-241
  • 75 Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease.  MMWR Morb Mortal Wkly Rep . 1998;  47 1-33
  • 76 Tanaka H, Tsukuma H, Hori Y. The risk of hepatitis C virus infection among blood donors in Osaka, Japan.  J Epidemiol . 1998;  8 292-296
  • 77 Mele A, Sagliocca L, Manzillo G. Risk factors for acute non-A, non-B hepatitis and their relationship to antibodies for hepatitis C virus: a case-control study.  Am J Public Health . 1994;  84 1640-1643
  • 78 Chiaramonte M, Stroffolini T, Lorenzoni U. Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy.  J Hepatol . 1996;  24 129-134
  • 79 Conry-Cantilena C, VanRaden M, Gibble J. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.  N Engl J Med . 1996;  334 1691-1696
  • 80 Lillienfeld A M, Lilienfeld D E. Foundations of Epidemiology.  New York: Oxford University Press 1980
  • 81 Conry-Cantilena C, Melpolder J C, Alter H J. Intranasal drug use among volunteer whole-blood donors: results of survey C.  Transfusion . 1998;  38 512-513
  • 82 Alter M J. Epidemiology of hepatitis C in the West.  Semin Liver Dis . 1995;  15 5-14
  • 83 Aach R D, Stevens C E, Hollinger F B. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.  N Engl J Med . 1991;  325 1325-1329
  • 84 Elia G F, Magnani G, Belli L. Incidence of anti-hepatitis C virus antibodies in non-A, non-B post-transfusion hepatitis in an area of northern Italy.  Infection . 1991;  19 336-339
  • 85 Mattsson L, Grillner L, von Sydow M. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden.  Infection . 1991;  19 309-312
  • 86 Goncales Jr L F, Pedro de J R, Da Silva J L. Post-transfusional hepatitis in the city of Campinas SP, Brazil. I. Incidence, etiological agents and clinico-epidemiological aspects of hepatitis C.  Rev Inst Med Trop Sao Paulo . 1993;  35 53-62
  • 87 Jullien A M, Courouce A M, Massari V. Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission.  Eur J Clin Microbiol Infect Dis . 1993;  12 668-672
  • 88 Donahue J G, Munoz A, Ness P M. The declining risk of post-transfusion hepatitis C virus infection.  N Engl J Med . 1992;  327 369-373
  • 89 Nelson K E, Ahmed F, Ness P. Comparison of first and second generation ELISA screening tests in detecting HCV infections in transfused cardiac surgery patients [abstract]. Program and Abstracts of the International Symposium on Viral Hepatitis and Liver Disease, 1993, p. 50
  • 90 Takano S, Nakamura K, Kawai S. Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis.  Hepatology . 1996;  23 708-712
  • 91 Gonzalez A, Esteban J I, Madoz P. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial.  Hepatology . 1995;  22 439-445
  • 92 Japanese Red Cross Non-A Non-B Hepatitis Research Group. Effect of screening for hepatitis C virus antibody and hepatitis B core antibody on incidence of post-transfusion hepatitis.  Lancet . 1991;  338 1040-1041
  • 93 Schreiber G B, Busch M P, Kleinman S H. The risk of transfusion-transmitted viral infections.  N Engl J Med . 1996;  334 1685-1690
  • 94 Alter M J, Coleman P J, Alexander W J. Importance of heterosexual activity in the transmission of hepatitis B and nonA, nonB hepatitis.  JAMA . 1989;  262 1201-1205
  • 95 Alter M J, Gerety R J, Smallwood L. Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban United States population.  J Infect Dis . 1982;  145 886-893
  • 96 Louie M, Low D E, Feinman S V. Prevalence of bloodborne infective agents among people admitted to a Canadian hospital.  Can Med Assoc J . 1992;  146 1331-1334
  • 97 Kelen G D, Green G B, Purcell R H. Hepatitis B and hepatitis C in emergency department patients.  N Engl J Med . 1992;  326 1399-1404
  • 98 Barham W B, Figueroa R, Phillips I A, Hyams K C. Chronic liver disease in Peru: role of viral hepatitis.  J Med Virol . 1994;  42 129-132
  • 99 Bile K, Aden C, Norder H. Important role of hepatitis C virus infection as a cause of chronic liver disease in Somalia.  Scand J Infect Dis . 1993;  25 559-564
  • 100 Guyer B, Bradley D W, Bryan J A, Maynard J E. Non-A, non-B hepatitis among participants in a plasmapheresis stimulation program.  J Infect Dis . 1979;  139 634-40
  • 101 Schvarcz R, Johansson B, Nystra;uom, Sönnerborg A. Nosocomial transmission of hepatitis C virus.  Infection . 1997;  25 74-77
  • 102 Allander T, Gruber A, Naghavi M. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward.  Lancet . 1995;  345 603-607
  • 103 Widell A, Christensson B, Wiebe T. Epidemiologic and molecular investigation of outbreaks of hepatitis C virus infection on a pediatric oncology service.  Ann Intern Med . 1999;  130 130-134
  • 104 Bronowicki J P, Venard V, Botte C. Patient to patient transmission of hepatitis C virus during colonoscopy.  N Engl J Med . 1997;  337 237-240
  • 105 Niu M T, Coleman P J, Alter M J. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and staff.  Am J Kidney Dis . 1993;  22 568-573
  • 106 Conlon P J, Walshe J J, Smyth E G. Lower prevalence of anti-hepatitis C antibody in dialysis and renal transplant patients in Ireland.  Irish J Med Sci . 1993;  162 145-147
  • 107 Bukh J, Wantzin P, Krogsgaard K. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection.  J Infect Dis . 1993;  168 1343-1348
  • 108 Kolho E, Oksanen K, Honkanen E. Hepatitis C antibodies in dialysis patients and patients with leukaemia.  J Med Virol . 1993;  40 318-321
  • 109 Nordenfelt E, Lofgren B, Widell A. Hepatitis C virus infection in hemodialysis patients in Southern Sweden: epidemiological, clinical, and diagnostic aspects.  J Med Virol . 1993;  40 266-270
  • 110 Medin C, Allander T, Roll M. Seroconversion to hepatitis C virus in dialysis patients: a retrospective and prospective study.  Nephron . 1993;  65 40-45
  • 111 Almroth G, Ekermo B, Franzen L, Hed J. Antibody responses to hepatitis C virus and its modes of transmission in dialysis patients.  Nephron . 1991;  59 232-235
  • 112 Hardy N M, Sandroni S, Danielson S, Wilson W J. Antibody to hepatitis C virus increases with time on hemodialysis.  Clin Nephrol . 1992;  38 44-48
  • 113 Zeldis J B, Depner T A, Kuramoto I K. The prevalence of hepatitis C virus antibodies among hemodialysis patients.  Ann Intern Med . 1990;  112 958-960
  • 114 Jeffers L J, Perez G O, DeMedina M D. Hepatitis C infection in two urban hemodialysis units.  Kidney Int . 1990;  38 320-322
  • 115 Forseter G, Wormser G P, Adler S. Hepatitis C in the health care setting. Seroprevalence among hemodialysis staff and patients in suburban New York City.  Am J Infec Control . 1993;  21 5-8
  • 116 Kallinowski B, Theilmann L, Gmelin K. Prevalence of antibodies to hepatitis C virus in hemodialysis patients.  Nephron . 1991;  59 236-238
  • 117 Schlipkoter U, Roggendorf M, Ernst G. Hepatitis C virus antibodies in haemodialysis patients [letter].  Lancet . 1990;  335 1409
  • 118 Tokars J I, Alter M J, Favero M S. National surveillance of dialysis associated diseases in the United States, 1993.  ASAIO J . 1996;  42 219-229
  • 119 Hayashi J, Yoshimura E, Nabeshima A. Seroepidemiology of hepatitis C virus infection in hemodialysis patients and the general population in Fukuoka and Okinawa, Japan.  J Gastroenterol . 1994;  29 276-281
  • 120 Fujiyama S, Kawano S, Sato S. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.  Hepatogastroenterology . 1995;  42 162-165
  • 121 Tsuyuguchi M. Prevalence of hepatitis C virus infection among chronic hemodialysis patients.  Hokkaido J Med Sci . 1994;  69 1178-1188
  • 122 DiLallo D, Miceli M, Petrosillo N. Risk factors of hepatitis C virus infection in patients on hemodialysis: a multivariate analysis based on a dialysis register in Central Italy.  Eur J Epidemiol . 1999;  15 11-14
  • 123 Covic A, Iancu L, Apetrei C. Hepatitis virus infection in haemodialysis patients from Moldavia.  Nephrol Dial Transplant . 1999;  14 40-45
  • 124 Fabrizi F, Lunghi G, Pagliari B. Molecular epidemiology of hepatitis C virus infection in dialysis patients.  Nephron . 1997;  77 190-196
  • 125 Halfon P, Khiri H, Feryn J M. Prospective virolocial follow-up of hepatitis C infection in a haemodialysis unit.  J Viral Hepat . 1998;  5 115-121
  • 126 Forns X, Fernandez-Llama P, Pons M. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit.  Nephrol Dial Transplant . 1997;  12 736-740
  • 127 Fabrizi F, Martin P, Dixit V. Detection of de novo hepatitis C virus infection by polymerase chain in hemodialysis patients.  Am J Nephrol . 1999;  19 383-388
  • 128 Jadoul M, Cornu C, Van Ypersele de Strihou C, UCL Collaborative Group. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study.  Kidney Int . 1993;  44 1322-1326
  • 129 Muller G Y, Zabaleta M E, Arminio A. Risk factors for dialysis-associated hepatitis C in Venezuela.  Kidney Int . 1992;  41 1055-1058
  • 130 Irie Y, Hayashi H, Yokozeki K. Hepatitis C infection unrelated to blood transfusion in hemodialysis patients.  J Hepatol . 1994;  20 557-559
  • 131 Noguchi S, Sata M, Suzuki H, Mizokami M, Tanikawa K. Routes of transmission of hepatitis C virus in an epidemic rural area of Japan. Molecular epidemiologic study of hepatitis C virus infection.  Scand J Infect Dis . 1997;  29 23-28
  • 132 Kiyosawa K, Tanaka E, Sodeyama T. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection.  Gastroenterology . 1994;  196 1596-1602
  • 133 Ito S, Ito M, Cho M-J, Shimotohno K, Tajima K. Massive sero-epidemiological survey of hepatitis C virus: clustering of carriers on the Southwest coast of Tsushima, Japan.  Jpn J Cancer Res . 1991;  82 1-3
  • 134 Frank C, Mohamed M K, Strickland G T. The role of antischistosomal therapy in the spread of hepatitis C virus in Egypt.  Lancet . 2000;  355 887-891
  • 135 Hutin Y JF, Harpaz R, Drobeniuc, et al. Injections given in healthcare settings as a major source of hepatitis B virus infection in Moldova.  Int J Epidemiol . 1999;  28 782-786
  • 136 Luby S P, Qamruddin K, Shah A A. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan.  Epidemiol Infect . 1997;  119 349-356
  • 137 Centers for Disease Control and Prevention. Frequency of vaccine-related and therapeutic injections-Romania, 1998.  MMWR Morb Mortal Wkly Rep . 1999;  48 271-274
  • 138 Esteban J I, Gomez J, Martell M. Transmission of hepatitis C virus by a cardiac surgeon.  N Engl J Med . 1996;  334 555-560
  • 139 Duckworth G J, Heptonstall J, Aitken C. Transmission of hepatitis C virus from a surgeon to a patient.  Commun Dis Public Health . 1999;  2 188-192
  • 140 Blackmore T K, Stace N H, Maddocks P. Prevalence of antibodies to HCV in patients receiving renal replacement therapy, and in the staff caring for them.  Aust NZJ Med . 1992;  22 353-357
  • 141 Thomas D L, Factor S H, Kelen G D. Viral hepatitis in health care personnel at The Johns Hopkins Hospital.  Arch Intern Med . 1993;  153 1705-1712
  • 142 Polish L B, Tong M J, Co R L. Risk factors for hepatitis C virus infection among health care personnel in a community hospital.  Am J Infect Control . 1993;  21 196-200
  • 143 Germanaud J, Barthez J P, Causse X. The occupational risk of hepatitis C infection among hospital employees.  Am J Public Health . 1994;  84 122
  • 144 Campello C, Majori S, Poli A. Prevalence of HCV antibodies in health-care workers from northern Italy.  Infection . 1992;  20 224-226
  • 145 Nakashima K, Kashiwagi S, Hayashi J. Low prevalence of hepatitis C virus infection among hospital staff and acupuncturists in Kyushu, Japan.  J Infect . 1993;  26 17-25
  • 146 Struve J, Aronsson B, Frenning B. Prevalence of antibodies against hepatitis C virus infection among health care workers in Stockholm.  Scand J Gastroenterol . 1994;  29 360-362
  • 147 Puro V, Petrosillo N, Ippolito G, Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. Risk of hepatitis C seroconversion after occupational exposures in health care workers.  Am J Infect Control . 1995;  23 273-277
  • 148 Lodi G, Porter S R, Teo C G, Scully C. Prevalence of HCV infection in health care workers of a UK dental hospital.  Br Dental J . 1997;  183 329-332
  • 149 Petrosilla N, Puro V, Ippolito G, Italian Study Group on Blood-borne Occupational Risk in Dialysis. Prevalence of hepatitis C antibodies in health-care workers.  Lancet . 1994;  343 1618-1620
  • 150 Cooper B W, Krusell A, Tilton R C. Seroprevalence of antibodies to hepatitis C virus in high-risk hospital personnel.  Infect Control Hosp Epidemiol . 1992;  13 82-85
  • 151 Panlilio A L, Shapiro C N, Schable C A. Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons.  J Am Coll Surg . 1995;  180 16-24
  • 152 Shapiro C N, Tokars J I, Chamberland M E, the American Academy of Orthopedic Surgeons Serosurvey Study Committee. Use of hepatitis B vaccine and infection with hepatitis B and C among orthopedic surgeons.  J Bone Joint Surg Am . 1996;  78 1791-1800
  • 153 Thomas D L, Gruninger S E, Siew C, Joy E D, Quinn T C. Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America.  Am J Med . 1996;  100 41-45
  • 154 Lanphear B P, Linnemann C C, Cannon C G. Hepatitis C virus infection in health care workers: risk of exposure and infection.  Infect Control Hosp Epidemiol . 1994;  15 745-750
  • 155 Mitsui T, Iwano K, Masuko K. Hepatitis C virus infection in medical personnel after needlestick accident.  Hepatology . 1992;  16 1109-1114
  • 156 Sartori M, La Terra G, Aglietta M. Transmission of hepatitis C via blood splash into conjunctiva.  Scand J Infect Dis . 1993;  25 270-271
  • 157 Ippolito G, Puro V, Petrosillo N, De Carli G, Micheloni G, Magliano E, Coordinating Centre of the Italian Study on Occupational Risk of HIV Infection. Simultaneous infection with HIV and hepatitis C virus following occupational conjunctival blood exposure.  JAMA . 1998;  280 28
  • 158 Aizaki H, Saito A, Kusakawa I. Mother-to-child transmission of a hepatitis C virus variant with an insertional mutation in its hypervariable region.  J Hepatol . 1996;  25 608-613
  • 159 Catalano D, Pollio F, Ercolano S. Maternal-fetal transmission of HCV.  Role of HIV as a risk factor. Min Ginecol . 1999;  51 117-119
  • 160 Fischler B, Lindh G, Lindgren S. Vertical transmission of hepatitis C virus infection.  Scand J Infect Dis . 1996;  28 353-356
  • 161 Giacchino R, Picciotto A, Tasso L. Vertical transmission of hepatitis C.  Lancet . 1995;  345 1122-1123
  • 162 Granovsky M, Minkoff H L, Tess B H. Hepatitis C virus infection in the Mothers and Infants Cohort Study.  Pediatrics . 1998;  102 355-359
  • 163 Kudesia G, Ball G, Irving W L. Vertical transmission of hepatitis C.  Lancet . 1995;  345 1122-1125
  • 164 Lam J PH, McOmish F, Burns S M. Infrequent vertical transmission of hepatitis C virus.  J Infect Dis . 1993;  167 572-576
  • 165 Latt N, Collins E, Spencer J. Hepatitis C virus infection in pregnant injecting drug users-possible vertical tranmission to babies. Proceeding of National Methadone Conference, Sydney, 1994
  • 166 Lin H H, Kao J H, Hsu H Y. Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus.  J Infect Dis . 1994;  169 638-641
  • 167 Maccabruni A, Bossi G, Caselli D. High efficiency of vertical transmission of hepatitis C virus among babies born to human immunodeficiency virus-negative women.  Pediatr Infect Dis J . 1995;  14 921-922
  • 168 Manzini P, Saracco G, Cerchier A. Human Immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus tranmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern.  Hepatology . 1995;  21 328-332
  • 169 Marcellin P, Bernuau J, Martinot-Peignoux M. Prevalence of hepatitis C virus infection in asymptomatic anti-HIV1 negative pregnant women and their children.  Dig Dis Sci . 1993;  38 2151-2155
  • 170 Mast E E, Hwang L Y, Seto D. Perinatal hepatitis C virus transmission: maternal risk factors and optimal timing of diagnosis.  Hepatology . 1999;  30(suppl., Part 2) 499A
  • 171 Moriya T, Sasaki F, Mizui M. Transmission of hepatitis C virus from mother to infants: its frequency and risk factors revisited. Biomed Pharmacother .  1995;  49 59-64
  • 172 Ni Y H, Lin H H, Chen P J. Temporal profile of hepatitis C virus antibody and genome in infants born to mother infected with hepatitis C virus but without human immunodeficiency virus coinfection.  J Hepatol . 1994;  20 641-645
  • 173 Novati R, Thiers V, D'Arminio Monforte A. Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction.  J Infect Dis . 1992;  165 720-723
  • 174 Ohto H, Terazawa S, Sasaki N. Transmission of hepatitis C virus from mothers to infants.  N Engl J Med . 1994;  330 744-750
  • 175 Paccagnini S, Principi N, Massironi E. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population.  Pediatr Infect Dis J . 1995;  14 195-199
  • 176 Palomba E, Manzini P, Fiammengo P. Natural history of perinatal hepatitis C virus infection.  Clin Infect Dis . 1996;  23 47-50
  • 177 Papaevangelou V, Pollack H, Rochford G. Increased transmission of vertical hepatitis C virus (HCV) infection to human immunodeficiency virus (HIV)-infected infants of HIV- and HCV-coinfected women.  J Infect Dis . 1998;  178 1047-1052
  • 178 Pipan C, Amici S, Astori G. Vertical transmission of hepatitis C virus in low-risk pregnant women.  Eur J Clin Microbiol Infect Dis . 1996;  14 116-120
  • 179 Reinus J F, Leikin E L, Alter H J. Failure to detect vertical transmission of hepatitis C virus.  Ann Intern Med . 1992;  117 881-886
  • 180 Resti M, Azzari C, Lega L. Mother-to-infant transmission of hepatitis C virus.  Acta Paediatr . 1995;  84 251-255
  • 181 Roudot-Thoraval F, Pawlotsky J-M, Thiers V. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing.  Hepatology . 1993;  17 722-777
  • 182 Sabatino G, Ramenghi L A, Di Marzio M, Pizzigallo E. Vertical transmission of hepatitis C virus: an epidemiological study on 2980 pregnant women in Italy.  Eur J Epidemiol . 1996;  12 443-447
  • 183 Soto B, Rodrigo L, Garcia Bengoechea M. Heterosexual transmission of HCV and the possible role of coexistent human immunodeficiency virus infection in the index case. A multicentre study of 432 pairings.  J Intern Med . 1994;  236 515-519
  • 184 Spencer J D, Latt N, Beeby P J. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission.  J Viral Hepat . 1997;  4 395-409
  • 185 Thomas D A, Villano S A, Riester K A. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study.  J Infect Dis . 1998;  177 1480-1488
  • 186 Uehara S, Abe Y, Saito T. The incidence of vertical transmission of HCV.  Tohoku J Exp Med . 1993;  171 195-202
  • 187 Wejstal R, Anders W, Mansson A S. Mother-to-infant transmission of hepatitis C virus.  Ann Intern Med . 1992;  117 887-890
  • 188 Zanetti A R, Tanzi E, Paccagnini S. Mother-to-infant transmission of hepatitis C virus.  Lancet . 1995;  345 289-291
  • 189 Zuccotti G V, Ribero M L, Giovannini M. Effect of hepatitis C genotype on mother-to-infant transmission of virus.  J Pediatr . 1995;  127 278-280
  • 190 Mast E E, Alter M J. Hepatitis C.  Semin Pediatr Infect Dis . 1997;  8 17-22
  • 191 Thomas D L, Zenilman J M, Alter H J. Sexual transmission of hepatitis C virus among patients attending Baltimore sexually transmitted diseases clinics-an analysis of 309 sex partnerships.  J Infect Dis . 1995;  171 768-775
  • 192 Osmond D H, Charlebois E, Sheppard H W. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men.  J Infect Dis . 1993;  167 66-71
  • 193 Corona R, Prignano G, Mele A. Heterosexual and homosexual transmission of hepatitis C virus: relation with hepatitis B virus and human immunodeficiency virus type 1.  Epidemiol Infect . 1991;  107 667-672
  • 194 Quaranta J F, Delaney S R, Alleman S. Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (Nice SEROCO cohort).  J Med Virol . 1994;  42 29-32
  • 195 Weinstock H S, Bolan G, Reingold A L, Polish L B. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases.  JAMA . 1993;  269 392-394
  • 196 Thomas D L, Cannon R O, Shapiro C N. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases.  J Infect Dis . 1994;  169 990-995
  • 197 van Doornum J J G, Hooykaas C, Cuypers M T. Prevalence of hepatitis C virus infections among heterosexuals with multiple partners.  J Med Virol . 1991;  35 22-27
  • 198 Mast E E, Darrow W W, Witte J. Hepatitis C virus infection among prostitutes: evidence for sexual transmission and protective efficacy of condoms [abstract]. Program and Abstracts of the Third International Symposium on HCV, Strasbourg, 1991, p. 95
  • 199 Gutierrez P, Orduna A, Bratos M A. Prevalence of anti-hepatitis C virus antibodies in positive FTA-ABS non-drug abusing female prostitutes in Spain.  Sex Trans Dis . 1992;  19 39-40
  • 200 Daikos G L, Lai S, Fischl M A. Hepatitis C virus infection in a sexually active inner city population. The potential for heterosexual transmission.  Infection . 1994;  22 72-76
  • 201 Hershow R C, Kalish L A, Sha B. Hepatitis C virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission.  Sex Trans Dis . 1998;  25 527-532
  • 202 Mesquita P E, Hernandez Granato F C, Castelo A. Risk factors associated with hepatitis C virus (HCV) infection among prostitutes and their clients in the city of Santos, Sao Paulo state, Brazil.  J Med Virol . 1997;  51 338-343
  • 203 Lissen E, Alter H J, Abad M A. Hepatitis C virus infection among sexually promiscuous groups and the hetersexual partners of hepatitis C virus infected index cases.  Eur J Clin Microbiol Infect Dis . 1993;  12 827-831
  • 204 Tedder R S, Gilson R J, Briggs M. Hepatitis C virus: evidence for sexual transmission.  BMJ . 1991;  302 1299-1302
  • 205 Donahue J G, Nelson K E, Munoz A. Antibody to HCV among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland.  Am J Epidemiol . 1991;  134 1206-1211
  • 206 Hyams K C, Phillips I A, Tejada A. Three year incidence study of retroviral and viral hepatitis transmission in a Peruvian prostitute population.  J AIDS . 1993;  6 1353-1357
  • 207 Osella A R, Massa M A, Joekes S. Hepatitis B and C virus sexual transmission among homosexual men.  Am J Gastroenterol . 1998;  93 49-52
  • 208 Gasparini V, Chiaramonte M, Moschen M E. Hepatitis C virus infection in homosexual men: A seroepidemiological study in gay clubs in north-east Italy.  Eur J Epidemiol . 1991;  7 665-669
  • 209 Westh H, Worm A M, Jensen B L. HCV antibodies in homosexual men and intravenous drug users in Denmark.  Infection . 1993;  21 115-117
  • 210 Sonnerborg A, Abebe A, Strannegard O. HCV infection in individuals with or without human immunodeficiency virus type 1 infection.  Infection . 1990;  18 347-351
  • 211 Williams C L, Mast E E, Coleman P J. Risk factors for sexual transmission of hepatitis C virus among non injecting-drug-using female prostitutes in the United States [abstract]. 36th Annual Meeting of the Infectious Disease Society of America, Denver, CO, 1998
  • 212 Bresters D, Mauser-Bunschoten E P, Reesink H W. Sexual transmission of hepatitis C virus.  Lancet . 1993;  342 210-211
  • 213 Meisel H, Reip A, Faltus B. Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin.  Lancet . 1995;  345 1209-1211
  • 214 David X R, Blanc P, Pageaux G P. Familial transmission of HCV.  Gastroenterol Clin Biol . 1995;  19 150-155
  • 215 Deny P, Roulot D, Asselot C. Low rate of hepatitis C virus (HCV) transmission within the family.  J Hepatol . 1992;  14 409-410
  • 216 Wyld R, Robertson J R, Brettle R P. Absence of hepatitis C virus transmission but frequent transmission of HIV-1 from sexual contact with doubly-infected individuals.  J Infect . 1997;  35 163-166
  • 217 Sachithanandan S, Fielding J F. Low rate of HCV transmission from women infected with contaminated anti-D immunoglobulin to their family contacts.  Ital J Gastroenterol Hepatol . 1997;  29 47-50
  • 218 Pachucki C T, Lentino J R, Schaaff D. Low prevalence of sexual transmission of hepatitis C virus in sex partners of seropositive intravenous drug users.  J Infect Dis . 1991;  164 820-821
  • 219 Eyster M E, Alter H J, Aledort L M. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).  Ann Intern Med . 1991;  115 764-768
  • 220 Gordon S C, Patel A H, Kulesza G W. Lack of evidence for the heterosexual transmission of hepatitis C.  Am J Gastroenterol . 1992;  87 1849-1851
  • 221 Tong M J, Lai P PC, Hwang S H. Evaluation of sexual transmission in patients with chronic hepatitis C infection.  Clin Diagn Virol . 1995;  3 39-47
  • 222 Scully L J, Mitchel S, Gill P. Clinical and epidemiologic characteristics of hepatitis C in a gastroenterology/hepatology practice in Ottawa.  Can Med Assoc J . 1993;  148 1173-1177
  • 223 Diaz Morant V, De La Mata M, Costan G. A low prevalence of antibodies to the hepatitis C virus in stable heterosexual couples.  Gastroenterol Hepatol . 1995;  18 111-113
  • 224 Garcia Bengoechea M, Cortes A, Lopez P. Intrafamilial spread of HCV infection.  Scand J Infect Dis . 1994;  26 15-18
  • 225 Soto B, Rodrigo L, Garcia Bengoechea M. Heterosexual transmission of HCV and the possible role of coexistent human immunodeficiency virus infection in the index case. A multicentre study of 432 pairings.  J Intern Med . 1994;  236 515-519
  • 226 Napoli N, Fiore G, Vella F. Prevalence of antibodies to hepatitis C virus among family members of patients with chronic hepatitis C.  Eur J Epidemiol . 1993;  9 629-632
  • 227 Gabrielli C, Zannini A, Corradini R. Spread of HCV among sexual partners of HCVAb positive intravenous drug users.  J Infect . 1994;  29 17-22
  • 228 Coltorti M, Caporaso N, Morisco F. Prevalence of HCV infection in the household contacts of patients with HCV-related chronic liver disease.  Infection . 1994;  22 183-186
  • 229 Guadagnino V, Stroffolini T, Foca A. Hepatitis C virus infection in family setting.  Eur J Epidemiol . 1998;  14 229-232
  • 230 Brusaferro S, Barbone F, Andrian P. A study on the role of the family and other risk factors in HCV transmission.  Eur J Epidemiol . 1999;  15 125-132
  • 231 Caporaso N, Ascione A, Stroffolini T. Spread of hepatitis C virus within families.  J Viral Hepat . 1998;  5 67-72
  • 232 Mondello P, Patti S, Vitale M G. Anti-HCV antibodies in household contacts of patients with cirrhosis of the liver-preliminary results.  Infection . 1992;  20 51-52
  • 233 Bellobuono A, Zanella A, Petrini G. Intrafamilial spread of hepatitis C virus.  Transfusion . 1991;  31 475
  • 234 Scaraggi F A, Lomuscio S, Perricci A. Intrafamilial and sexual transmission of hepatitis C virus.  Lancet . 1993;  342 1300-1301
  • 235 Saltoglu N, Tasova Y, Burgut R, Dundar I H. Sexual and non-sexual intrafamilial spread of hepatitis C virus: intrafamilial transmission of HCV.  Eur J Epidemiol . 1998;  14 225-228
  • 236 Oshita M, Hayashi N, Kasahara A. Prevalence of HCV in family members of patients with hepatitis C.  J Med Virol . 1993;  41 251-255
  • 237 Setoguchi Y, Kajihara S, Hara T. Analysis of nucleotide sequences of HCV isolates from husband-wife pairs.  J Gastroenterol Hepatol . 1994;  9 468-471
  • 238 Nakashima K, Ikematsu H, Hayashi J. Intrafamilial transmission of hepatitis C virus among the population of an endemic area of Japan.  JAMA . 1995;  274 1459-1461
  • 239 Kao J H, Chen P J, Yang P M. Intrafamilial transmission of HCV: The important role of infections between spouses.  J Infect Dis . 1994;  170 1128-1133
  • 240 Kim Y S, Chi H S, Ahn Y O. Lack of familial clustering of hepatitis C virus infection.  Int J Epidemiol . 1998;  27 525-529
  • 241 Brackmann S A, Gerritzen A, Oldenburg J. Search for intrafamilial transmission of HCV in hemophilia patients.  Blood . 1993;  81 1077-1082
  • 242 Camarero C, Martos I, Delgado R. Horizontal transmission of hepatitis C virus in households of infected children.  J Pediatr . 1993;  123 98-99
  • 243 Vegnente A, Iorio R, Saviano A. Lack of intrafamilial transmission of hepatitis C virus in family members of children with chronic hepatitis C infection.  Pediatr Infect Dis J . 1994;  886-889
  • 244 Kaldor J M, Archer G T, Buring M L. Risk factors for hepatitis C virus infection in blood donors: a case-control study.  Med J Australia . 1992;  157 227-230
  • 245 Sun D X, Zhang F G, Geng Y Q. Hepatitis C transmission by cosmetic tattooing in women.  Lancet . 1996;  347 541
  • 246 Tumminelli F, Marcellin P, Rizzo S. Shaving as a potential source of hepatitis C virus infection.  Lancet . 1995;  345 658
  • 247 Mele A, Corona R, Tosti M E. Beauty treatments and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in Italy.  Scand J Infect Dis . 1995;  27 441-444
  • 248 Balasekaran R, Bulterys M, Jamal M. A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States.  Am J Gastroenterol . 1999;  94 1341-1346
  • 249 EASL International Consensus Conference on Hepatitis C. Consensus statement.  J Hepatol . 1999;  30 956-961
    >